Results 171 to 180 of about 846,419 (356)

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Covered intestinal endoprosthesis for the management of enteroatmospheric fistula, case report and review of the literature [PDF]

open access: diamond, 2023
Ediel O. Dávila-Ruiz   +4 more
openalex   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Intestinal fistula secondary to umbilical hernia repair with polypropylene mesh [PDF]

open access: diamond, 2019
Sonia Morales Artero   +4 more
openalex   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos   +4 more
wiley   +1 more source

Mono‐dimensional, two‐dimensional and Doppler echocardiographic measurements in healthy Standardbred neonatal foals in the first 5 days of life

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Bodyweight, age and breed influence the echocardiographic assessment of foals. There are no echocardiographic studies in Standardbred neonatal foals. Objectives To describe echocardiographic values for selected variables, evaluate intra‐ and inter‐observer variability and assess cardiac changes in the first 5 days of life in healthy
Fernanda Timbó D'el Rey Dantas   +8 more
wiley   +1 more source

¿Son útiles la somatostatina y sus análogos (octreótido y lanreótido) en el manejo del paciente con fístula entero-cutánea?: Revisión sistemática de la literatura

open access: yesRevista Colombiana de Cirugía
Introducción. Las fístulas entero-cutáneas son una complicación infrecuente pero catastrófica para el paciente quirúrgico. En su manejo, el uso de la somatostatina y de sus análogos (octreótido/ lanreótido) se indica con frecuencia pero los resultados ...
Luis Carlos Domínguez   +3 more
doaj  

Alginate Oligosaccharides Attenuate Ochratoxin A‐Induced Liver Injury through Regulating the Interaction of Nrf2 and NF‐κB Signaling Pathways

open access: yesFood Frontiers, EarlyView.
A schematic illustration for the protective effects of AOS on OTA‐induced liver injury in mice. AOS, alginate oligosaccharides; CAT, catalase; GSTT1, glutathione S‐transferase theta 1; HO‐1, heme oxygenase 1; IκBα, inhibitor kappa B alpha; IL‐1β, interleukin‐1β; IL‐6, interleukin‐6; Keap1, kelch‐like ech‐associated protein 1; NF‐κB, nuclear factor ...
Yue Zhao   +8 more
wiley   +1 more source

Pancreatic fistulas in pancreatic transplantation. [PDF]

open access: yes, 1992
C Gebhardt   +21 more
core   +1 more source

Home - About - Disclaimer - Privacy